African Medicines Agency and Medicines for Africa Collaborate to Tackle Substandard Medicines Johannesburg, South Africa — The African Medicines Agency (AMA) and Medicines for Africa (MFA) have joined forces to combat the proliferation of substandard and falsified medical products across the continent. This strategic partnership, formalized through a Memorandum of Understanding (MoU), aims to bolster advocacy and communication efforts, ensuring that regulatory excellence translates into safer outcomes for patients and stronger public confidence in medical products.
The AMA, a specialized agency of the African Union, was established to enhance regulatory cooperation and improve access to safe, quality, and efficacious medical products. Dr. Delese Mimi Darko, the Director-General of the AMA, emphasized the importance of addressing the fragmented supply chains and regulatory oversight that allow substandard and falsified medical products to reach patients.
Medicines for Africa, an African — led patient safety organization, brings extensive experience in advocacy and communications to the table. Dr. Lenias Hwenda, the Founder and CEO of MFA, highlighted the shared commitment to patient safety and the joint efforts to combat the circulation of unsafe medical products.
The partnership will focus on several key areas, including strengthening regulatory systems, enhancing market access for quality — assured health products, and supporting local manufacturing.
The World Health Organization (WHO) has been instrumental in this endeavor, with the two organizations signing a Framework Agreement for Collaboration.
The impact of this collaboration is expected to be far — reaching, improving the quality and safety of medicines available in Africa and reducing the burden of diseases such as malaria and HIV/AIDS.
The establishment of a robust regulatory framework will not only protect patients from unsafe medicines but also foster innovation and investment in the pharmaceutical sector.
As the AMA continues to operationalize its regulatory systems, the focus will be on ensuring that quality — assured health products are accessible to all African citizens. This will require a coordinated effort from governments, healthcare providers, and the private sector.
The AMA’s commitment to protecting patients from unsafe medicines is a crucial step towards achieving universal health coverage in Africa. With the support of partners like MFA and the WHO, the AMA is poised to make a meaningful impact on the continent’s healthcare landscape.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Panafricanvisions
Source: Pan African Visions
